Viagra and Drugmakers: A Risky Investment ?

The storied success of copyright’s flagship drug has undeniably transformed the healthcare landscape. However, putting money in companies heavily focused on biosimilars and the diminishing patent protection surrounding this iconic medication presents a considerable degree of risk . While major ph

read more